Xufeng Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xufeng Han has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dao-Quan Tang
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
1 shared publication - Quangang Chen
Xuzhou Medical University
1 shared publication - Renjin Chen
School of Life Sciences, Xuzhou Medical University
1 shared publication - Xuemei Xian
Laboratory Animal Center, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China
1 shared publication - Yingchao Bi
Laboratory Animal Center, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China
1 shared publication - Yuhua Zhu
Institute of Cellular and Molecular Biology, College of Life Science, Jiangsu Normal University, Xuzhou, People’s Republic of China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 23 August 2018
- Published by MDPI AG in Biomolecules
- Vol. 8 (3) , 80
Research Progress on the Relationship between Atherosclerosis and Inflammation
Atherosclerosis is a chronic inflammatory disease; unstable atherosclerotic plaque rupture, vascular stenosis, or occlusion caused by platelet aggregation and thrombosis lead to acute cardiovascular disease. Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on atherosclerosis, the role of related signaling pathways in inflammation, the formation of atherosclerosis plaques, and the prospects of treating atherosclerosis by inhibiting inflammation.
- 23 August 2018
- Published by MDPI AG in Biomolecules
- Vol. 8 (3) , 80
Top Cited PapersOpen AccessResearch Progress on the Relationship between Atherosclerosis and Inflammation
Atherosclerosis is a chronic inflammatory disease; unstable atherosclerotic plaque rupture, vascular stenosis, or occlusion caused by platelet aggregation and thrombosis lead to acute cardiovascular disease. Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on atherosclerosis, the role of related signaling pathways in inflammation, the formation of atherosclerosis plaques, and the prospects of treating atherosclerosis by inhibiting inflammation.